Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Kirkpatrick

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Annals of Pharmacotherapy|October 26, 2001
Comment: serum concentrations of cefuroxime after continuous infusion in coronary bypass graft patientsC M Kirkpatrick, G Howard, J Vella-Brincat
Antimicrobial Agents and Chemotherapy|April 1, 1997
Once-daily aminoglycoside therapy: potential ototoxicityC M Kirkpatrick, S B Duffull, E J Begg
British Journal of Clinical Pharmacology|September 21, 2001
The therapeutic monitoring of antimicrobial agentsE J Begg, M L Barclay, C M Kirkpatrick
British Journal of Clinical Pharmacology|June 26, 1999
Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once dailyC M Kirkpatrick, S B Duffull, E J Begg
Clinical Pharmacokinetics|March 27, 1999
Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?M L Barclay, C M Kirkpatrick, E J Begg
Journal of Wildlife Diseases|October 1, 1980
Possible role of wild mammals in transmission of pseudorabies to swineC M Kirkpatrick, C L Kanitz, S M McCrocklin
BMJ (Clinical Research Ed.)|August 24, 1996
Single or multiple daily doses of aminoglycosides. Exposure to aminoglycosides should be monitored during treatmentE J Begg, S B Duffull, C M Kirkpatrick
British Journal of Clinical Pharmacology|February 1, 1997
Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimensS B Duffull, C M Kirkpatrick, E J Begg
Clinical Pharmacology and Therapeutics|November 22, 2012
Physiologically based pharmacokinetic modeling at the extremes of ageC Johnston, C M Kirkpatrick, A J McLachlan, et al.
Adverse Drug Reactions and Toxicological Reviews|February 24, 2001
Genetic polymorphism and outcomes with azathioprine and 6-mercaptopurineS J Gardiner, E J Begg, M L Barclay, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|October 26, 2001
Comment: serum concentrations of cefuroxime after continuous infusion in coronary bypass graft patientsC M Kirkpatrick, G Howard, J Vella-Brincat
Antimicrobial Agents and Chemotherapy|April 1, 1997
Once-daily aminoglycoside therapy: potential ototoxicityC M Kirkpatrick, S B Duffull, E J Begg
British Journal of Clinical Pharmacology|September 21, 2001
The therapeutic monitoring of antimicrobial agentsE J Begg, M L Barclay, C M Kirkpatrick
British Journal of Clinical Pharmacology|June 26, 1999
Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once dailyC M Kirkpatrick, S B Duffull, E J Begg
Clinical Pharmacokinetics|March 27, 1999
Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?M L Barclay, C M Kirkpatrick, E J Begg
Journal of Wildlife Diseases|October 1, 1980
Possible role of wild mammals in transmission of pseudorabies to swineC M Kirkpatrick, C L Kanitz, S M McCrocklin
BMJ (Clinical Research Ed.)|August 24, 1996
Single or multiple daily doses of aminoglycosides. Exposure to aminoglycosides should be monitored during treatmentE J Begg, S B Duffull, C M Kirkpatrick
British Journal of Clinical Pharmacology|February 1, 1997
Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimensS B Duffull, C M Kirkpatrick, E J Begg
Clinical Pharmacology and Therapeutics|November 22, 2012
Physiologically based pharmacokinetic modeling at the extremes of ageC Johnston, C M Kirkpatrick, A J McLachlan, et al.
Adverse Drug Reactions and Toxicological Reviews|February 24, 2001
Genetic polymorphism and outcomes with azathioprine and 6-mercaptopurineS J Gardiner, E J Begg, M L Barclay, et al.
Pageof 2